The company’s product is a generic version of Daiichi Sankyo’s Azor tablets
Drug firm Ajanta Pharma has launched blood pressure lowering tablets in the US market. After the approval of the United States Food and Drug Administration (US FDA), the company has launched Amlodipine + Olmesartan Medoxomil tablets in the US market through its arm, Ajanta Pharma USA,” the company said in a BSE filing.
The company’s product is a generic version of Daiichi Sankyo’s Azor tablets, it added.
The product has been launched in four strengths 5mg+20mg, 5mg+40mg, 10mg+20mg and 10mg+40mg, Ajanta Pharma said.
“Amlodipine + Olmesartan Medoxomil tablets is part of an ever growing portfolio of products that Ajanta has developed for the US market,” it added.
In total, the company has 29 Abbreviated New Drug Applications (ANDA) of which 16 are final ANDA approvals, two tentative approvals and 11 ANDAs are under review with US FDA, Ajanta Pharma said.
EP News Bureau